BCL2L1 and Thrombocytopenia: We used immunotoxin doses shown to be non-toxic in this mouse model [34] and ABT-737 doses which did not elicit thrombocytopenia, which is known to be the most adverse side effect in patients due to platelet dependence on Bcl-xl [52].